Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
-
+
P01.24 - Ramucirumab + Docetaxel (DOC) vs PBO + DOC for Stage IV NSCLC after Disease Progression (REVEL): Indian Sub-Group Analysis
00:00 - 00:00 | Presenter: Kumar Prabhash
- Abstract
Loading...
-
+
P33 - Pathology - Immunotherapy Biomarker
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
-
+
P33.18 - The Prevalence of PDL-1 Expression in Lung Cancer: Real-World Experience from a Tertiary Care Oncology Centre
00:00 - 00:00 | Presenter: Rajiv Kumar
- Abstract
Loading...
-
+
P37 - Pathology - Biomarker Testing
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
-
+
P37.14 - Comparative Evaluation of IHC versus FISH for Detection of ROS1 Fusion in Lung Cancer
00:00 - 00:00 | Presenter: Rajiv Kumar
- Abstract
Loading...
-
+
P76 - Targeted Therapy - Clinically Focused - EGFR
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
-
+
P76.26 - Survival Outcomes in Patients Receiving Second Line Osimertinib Post First Line First Generation TKI Alone or in Combination with Chemotherapy
00:00 - 00:00 | Presenter: Satvik Khaddar
- Abstract
Loading...
-
+
P82 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Radiotherapy
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
-
+
P82.03 - Immunotherapy in Combination with Hypofractionated Radiotherapy for Lung Cancer: A Real-World Experience
00:00 - 00:00 | Presenter: Naveen Mummudi
- Abstract
Loading...
-
+
OA05 - Value and Quality in Lung Cancer
- 15:30 - 16:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Health Services Research/Health Economics
-
+
OA05.03 - Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study
15:30 - 15:40 | Presenter: Abdul Rahman Jazieh
- Abstract
Loading...